Apalutamide-induced severe agranulocytosis: a case report
10.3760/cma.j.cn112330-20230905-00064
- VernacularTitle:阿帕他胺致严重粒细胞缺乏1例报告
- Author:
Wei LIU
1
;
Baolong PENG
;
Junxin WANG
;
Xingkang JIANG
;
Ranlu LIU
Author Information
1. 天津医科大学第二医院泌尿外科,天津 300211
- Keywords:
Prostatic neoplasms;
Agranulocytosis;
Apalutamide;
Adverse reaction
- From:
Chinese Journal of Urology
2024;45(1):65-66
- CountryChina
- Language:Chinese
-
Abstract:
Adverse reactions commonly associated with apalutamide include hot flashes, fatigue, joint pain, rash, hypertension, and anemia. Apalutamide-induced agranulocytosis is relatively rare. In this paper, we reported a case with metastatic hormone-sensitive prostate cancer who developed agranulocytosis after taking apalutamide for one month. The patient’s neutrophil count returned to normal with appropriate supportive therapy, and no significant decrease in neutrophil count was observed during 10 months of follow-up after discharge.